SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-239422
Filing Date
2022-09-07
Accepted
2022-09-07 06:49:04
Documents
17
Period of Report
2022-09-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d396958d8k.htm   iXBRL 8-K 40336
2 EX-2.1 d396958dex21.htm EX-2.1 235027
3 EX-10.1 d396958dex101.htm EX-10.1 11780
4 EX-10.2 d396958dex102.htm EX-10.2 11885
8 GRAPHIC g396958g0907044030662.jpg GRAPHIC 3995
9 GRAPHIC g396958g0907044348190.jpg GRAPHIC 3728
  Complete submission text file 0001193125-22-239422.txt   512760

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA imra-20220906.xsd EX-101.SCH 2845
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20220906_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20220906_pre.xml EX-101.PRE 11700
11 EXTRACTED XBRL INSTANCE DOCUMENT d396958d8k_htm.xml XML 3455
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 221229881
SIC: 2834 Pharmaceutical Preparations